HSE Approves Skyclarys Reimbursement for FA Patients

"A landmark day": HSE approves reimbursement of Skyclarys drug

HSE Drugs Group recommendation earlier this month sparked protests The post “A landmark day”: HSE approves reimbursement of Skyclarys drug appeared first on Gript.

Decision due on Skyclarys funding as Biogen reportedly makes lower price offer

Families affected by Friedreich’s ataxia remain hopeful as the HSE considers the treatment’s cost and benefits for patients

HSE senior management team to make final decision on Friedrich Ataxia drug funding

People suffering from rare disease ‘beg’ for life-changing medicine

HSE approves Skyclarys reimbursement for FA patients

The HSE has approved the reimbursement of the drug Skyclarys for people with Friedreich's ataxia.

O'Meara: Government needs to implement HSE approval of Skyclarys

Funding has been approved for Skyclarys for patients with Friedreich’s Ataxia. The HSE’s Senior Management Team has this afternoon approved the reimbursement of the treatment, after drug firm Biogen made a “substantially improved financial offer” to the health service. Earlier this month, the HSE’s Drugs Group recommended the drug NOT be reimbursed over concerns about […] The post O’Meara: Government needs to implement HSE approval of Skyclarys …